Dr Reddys signs agreement for distribution of Takeda's dengue vaccine in India
· Business Standard Mkts, BS Companies
The collaboration follows the approval of QDENGA's marketing authorization by India's Central Drugs Standard Control Organization (CDSCO) in July 2026 for individuals aged 4-60 years. As India's first approved dengue vaccine, the approval marks an important milestone in the country's efforts to strengthen dengue prevention and management.